Bill Clinton: “Yes. So let's just suppose that happened. And what you would want is to be able to take a blood sample, do an analysis…”

“Yes. So let's just suppose that happened. And what you would want is to be able to take a blood sample, do an analysis, put it through a software program that had already been developed, and say, ``Okay, here is--this is how the genes are different. This is the difference.'' And then presumably, not too long after we've developed this, they will already know, well, therefore, this is how you should-- how you should change the vaccine. And we know now--I know this is kind of bewildering, but keep in mind this is actually good news because, if there were no genome project, if there were no rapid way to do quick analysis that would go right to the tiniest variant, we would be in trouble. And now these scientists are working on this, and we're actually a little bit ahead of the original predicted timetable on unlocking the secrets of the gene. And when that happens, one of the side benefits, I think, will be to be able to tell these things much more quickly. But meanwhile, we've got this plan. We're stockpiling the vaccines, and we're doing all this research which the Government has to fund, because obviously there's no market for it, right? It's not like-- there's no market for it, and I hope there never will be any market for it. But we have to pay, the Government has to pay for this research to develop new vaccines and to manage it along. And I think we will do--I think we've got a very good increase in the budget, and I really think it will have broad bipartisan support.”